Manufacturing

Feliza Mirasol is the science editor for 

Articles

Digital transformation is allowing for better handling, analysis, and protection of vast data collection.

Shoring Up Data Integrity Practices

In a new agreement, Cellares will utilize its Cell Shuttle fully automated cell therapy manufacturing platform to manufacture select CAR-T cell therapies under development by Bristol Myers Squibb. 

Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal

Videos

Jay Rajagopalan, senior director—Engineering & Product Management for Malema at PSG Biotech, shared insights at on how current industry trends are shaping the development and advancement of sensor technologies.

A Look at the Impact of Industry Trends on Sensor Technologies (INTERPHEX 2024)

This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma industry.

Drug Digest: The Rush for Quality Data and the Means to Protect It

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Effective analytics will eliminate failures, deviations, and non-conformances.

Analyzing Exabytes

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

European bio/pharma companies have no choice but to invest and adapt to the evolving industry needs.

Bridging Gaps and Investing in Change

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

Mark Featherston is director, quality, strategic programs and global lab services at Avantor.

John D. Fisher is director, engineering, global ops at Avantor.

Digital transformation allows for smarter and connected biomanufacturing operations.

Revolutionizing Biomanufacturing: The Digitalization Advantage

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.

Process Control, Automation, and PAT